MA50774B1 - Procédé de production d'un dérivé de diphénylméthane - Google Patents
Procédé de production d'un dérivé de diphénylméthaneInfo
- Publication number
- MA50774B1 MA50774B1 MA50774A MA50774A MA50774B1 MA 50774 B1 MA50774 B1 MA 50774B1 MA 50774 A MA50774 A MA 50774A MA 50774 A MA50774 A MA 50774A MA 50774 B1 MA50774 B1 MA 50774B1
- Authority
- MA
- Morocco
- Prior art keywords
- synthetic route
- diphenylmethane derivative
- producing
- linear synthetic
- sglt
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 5
- CZZYITDELCSZES-UHFFFAOYSA-N diphenylmethane Chemical class C=1C=CC=CC=1CC1=CC=CC=C1 CZZYITDELCSZES-UHFFFAOYSA-N 0.000 title abstract 2
- 238000004519 manufacturing process Methods 0.000 abstract 2
- 102100037202 Sodium/myo-inositol cotransporter 2 Human genes 0.000 abstract 1
- 101710090560 Sodium/myo-inositol cotransporter 2 Proteins 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
- 238000010189 synthetic method Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D9/00—Crystallisation
- B01D9/005—Selection of auxiliary, e.g. for control of crystallisation nuclei, of crystal growth, of adherence to walls; Arrangements for introduction thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B51/00—Introduction of protecting groups or activating groups, not provided for in the preceding groups
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Crystallography & Structural Chemistry (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Saccharide Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrane Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
La présente invention concerne un procédé amélioré de production d'un dérivé de diphénylméthane qui est efficace comme inhibiteur du cotransporteur du glucose dépendant du sodium (sglt), le procédé étant exécuté à l'aide d'un procédé de synthèse convergent dans lequel chaque groupe majeur est séparément synthétisé et ensuite couplé. Ainsi, comparativement à un procédé de synthèse linéaire présenté dans les documents existants, la voie de synthèse est compacte et le rendement peut être accru, et les facteurs de risque inhérents à la voie de synthèse linéaire peuvent être réduits. En outre, la forme cristalline du composé produit selon le procédé offre de superbes caractéristiques physico-chimiques, et ainsi peut être efficacement utilisée dans les domaines tels que la fabrication pharmaceutique.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20160075910 | 2016-06-17 | ||
| PCT/KR2017/006271 WO2017217792A1 (fr) | 2016-06-17 | 2017-06-15 | Procédé de production d'un dérivé de diphénylméthane |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MA50774A1 MA50774A1 (fr) | 2021-03-31 |
| MA50774B1 true MA50774B1 (fr) | 2022-02-28 |
Family
ID=60664449
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA44545A MA44545B2 (fr) | 2016-06-17 | 2017-06-15 | Procédé de production d'un dérivé de diphénylméthane |
| MA50774A MA50774B1 (fr) | 2016-06-17 | 2017-06-15 | Procédé de production d'un dérivé de diphénylméthane |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA44545A MA44545B2 (fr) | 2016-06-17 | 2017-06-15 | Procédé de production d'un dérivé de diphénylméthane |
Country Status (29)
| Country | Link |
|---|---|
| US (2) | US10640496B2 (fr) |
| EP (2) | EP3473621B1 (fr) |
| JP (4) | JP6763978B2 (fr) |
| KR (2) | KR102233229B1 (fr) |
| CN (2) | CN113651803B (fr) |
| AU (1) | AU2017285813B2 (fr) |
| CA (2) | CA3081033C (fr) |
| CL (1) | CL2018003645A1 (fr) |
| CO (1) | CO2018014018A2 (fr) |
| DK (2) | DK3473621T3 (fr) |
| DO (1) | DOP2018000287A (fr) |
| EC (1) | ECSP19000185A (fr) |
| ES (2) | ES2898336T3 (fr) |
| HR (1) | HRP20211670T8 (fr) |
| HU (1) | HUE056428T2 (fr) |
| MA (2) | MA44545B2 (fr) |
| MX (2) | MX385640B (fr) |
| MY (1) | MY203941A (fr) |
| NZ (1) | NZ749398A (fr) |
| PE (2) | PE20240590A1 (fr) |
| PH (1) | PH12018550206A1 (fr) |
| PL (2) | PL3473621T3 (fr) |
| PT (2) | PT3473621T (fr) |
| RS (1) | RS62550B1 (fr) |
| SA (2) | SA521422474B1 (fr) |
| SG (2) | SG11201811154QA (fr) |
| SI (1) | SI3663292T1 (fr) |
| TN (1) | TN2018000437A1 (fr) |
| WO (1) | WO2017217792A1 (fr) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102011054773A1 (de) | 2011-10-25 | 2013-04-25 | Vb Autobatterie Gmbh & Co. Kgaa | Anschlusspol für einen Akkumulator, Akkumulatorgehäuse und Maschine zur Herstellung eines Anschlusspols |
| ES2980368T3 (es) * | 2018-08-13 | 2024-10-01 | Daewoong Pharmaceutical Co Ltd | Método para producir un intermediario útil para la síntesis de inhibidor de SGLT |
| CN112341416A (zh) * | 2019-08-09 | 2021-02-09 | 天津津艺医药科技发展有限责任公司 | 一种制备苯并含氧脂杂环衍生物的方法 |
| EP4112612B1 (fr) | 2020-02-27 | 2025-10-22 | Daewoong Pharmaceutical Co., Ltd. | Intermédiaire utile pour la synthèse d'un inhibiteur de sglt et procédé de préparation d'un inhibiteur de sglt l'utilisant |
| CN112094253B (zh) * | 2020-09-10 | 2023-01-10 | 株式会社大熊制药 | 用于制备sglt抑制剂中间体的合成方法 |
| US12448360B2 (en) * | 2020-09-10 | 2025-10-21 | Daewoong Pharmaceutical Co., Ltd. | Synthesis method for preparing SGLT inhibitor intermediate |
| CN113200860B (zh) * | 2021-04-29 | 2024-07-30 | 爱斯特（成都）生物制药股份有限公司 | 一种sglt2抑制剂中间体的制备方法 |
| KR20230046784A (ko) * | 2021-09-30 | 2023-04-06 | 주식회사 대웅제약 | 이나보글리플로진을 포함하는 약학 조성물 |
| CN113801010A (zh) * | 2021-11-18 | 2021-12-17 | 山东诚创蓝海医药科技有限公司 | 一种5-溴-2-氯苯甲酸的制备方法 |
| CN113912487B (zh) * | 2021-11-23 | 2024-05-28 | 山东研峰新材料科技有限公司 | 一种2,5-双卤代苯甲酸的合成方法 |
| KR20230110001A (ko) * | 2022-01-14 | 2023-07-21 | 주식회사 대웅제약 | Ssglt 저해제의 합성에 유용한 중간체의 제조 방법 |
| KR20240044194A (ko) * | 2022-09-28 | 2024-04-04 | 주식회사 대웅제약 | 이나보글리플로진의 신규한 공결정 |
| KR20240044190A (ko) * | 2022-09-28 | 2024-04-04 | 주식회사 대웅제약 | 이나보글리플로진의 신규한 결정형 및 이의 제조방법 |
| JP2025532992A (ja) | 2022-09-29 | 2025-10-03 | デーウン ファーマシューティカル カンパニー リミテッド | エナボグリフロジンを含む心血管老化疾患の予防又は治療用薬学組成物｛ｐｈａｒｍａｃｅｕｔｉｃａｌ ｃｏｍｐｏｓｉｔｉｏｎ ｆｏｒ ｐｒｅｖｅｎｔｉｎｇ ｏｒ ｔｒｅａｔｉｎｇ ｃａｒｄｉｏｖａｓｃｕｌａｒ ａｇｉｎｇ ｄｉｓｅａｓｅｓ ｃｏｎｔａｉｎｉｎｇ ｅｎａｖｏｇｌｉｆｌｏｚｉｎ｝ |
| MA71282A1 (fr) | 2022-10-05 | 2025-12-31 | Daewoong Pharmaceutical Co., Ltd. | Composition pharmaceutique pour la prévention ou le traitement d'une néphropathie et/ou du diabète sucré, comprenant de l'énavogliflozine |
| EP4631498A1 (fr) | 2022-12-21 | 2025-10-15 | Daewoong Therapeutics Inc. | Composition pharmaceutique de type gouttes ophtalmiques contenant de l'envogliflozine |
| KR20240107660A (ko) | 2022-12-30 | 2024-07-09 | 주식회사 대웅제약 | 이나보글리플로진 및 메트포르민을 포함하는 약학 조성물 |
| KR102837941B1 (ko) * | 2024-11-13 | 2025-07-25 | 대웅바이오(주) | Inline quenching 공정을 도입한 연속반응 공정을 이용한 이나보글리플로진 합성방법 |
| KR102837948B1 (ko) * | 2024-11-13 | 2025-07-25 | 대웅바이오(주) | 분배 투입법을 도입한 연속반응 공정을 이용한 이나보글리플로진 합성방법 |
| KR102853437B1 (ko) * | 2024-11-13 | 2025-09-04 | 대웅바이오(주) | 연속반응 공정을 이용한 이나보글리플로진 합성방법 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4966907A (en) * | 1988-08-12 | 1990-10-30 | Merck & Co., Inc. | 6-substituted 5-hydroxy-2,3-dihydrobenzofurans as inhibitors of leukotriene biosynthesis |
| CN103214471B (zh) * | 2003-08-01 | 2018-02-06 | 田边三菱制药株式会社 | 具有钠依赖型葡萄糖转运体抑制活性的化合物的制备方法 |
| ATE530558T1 (de) | 2007-07-26 | 2011-11-15 | Lexicon Pharmaceuticals Inc | Verfahren und verbindungen zur herstellung von natriumglucose-co-transporter-2-hemmern |
| MX2011001062A (es) * | 2008-07-30 | 2011-03-24 | Ferrer Int | Compuestos de 1,6-dihidro-2h-3-oxa-6-aza-as-indaceno. |
| US8163704B2 (en) | 2009-10-20 | 2012-04-24 | Novartis Ag | Glycoside derivatives and uses thereof |
| WO2012041898A1 (fr) * | 2010-09-29 | 2012-04-05 | Celon Pharma Sp. Z O.O. | Combinaison de l'inhibiteur de sglt2 et d'un composé de sucre pour le traitement du diabète |
| TR201903445T4 (tr) * | 2011-06-01 | 2019-03-21 | Green Cross Corp | Sglt2 i̇nhi̇bi̇törleri̇ olarak yeni̇ di̇feni̇lmetan türevleri̇ |
| US9340521B2 (en) * | 2013-03-18 | 2016-05-17 | Green Cross Corporation | Method for dual inhibition of SGLT1 and SGLT2 using diphenylmethane derivatives |
| FR3017868A1 (fr) | 2014-02-21 | 2015-08-28 | Servier Lab | Derives d'isoquinoleine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
-
2017
- 2017-06-15 US US16/310,005 patent/US10640496B2/en active Active
- 2017-06-15 SI SI201730944T patent/SI3663292T1/sl unknown
- 2017-06-15 PE PE2023002240A patent/PE20240590A1/es unknown
- 2017-06-15 PT PT17813615T patent/PT3473621T/pt unknown
- 2017-06-15 EP EP17813615.6A patent/EP3473621B1/fr active Active
- 2017-06-15 KR KR1020170075799A patent/KR102233229B1/ko active Active
- 2017-06-15 SG SG11201811154QA patent/SG11201811154QA/en unknown
- 2017-06-15 TN TNP/2018/000437A patent/TN2018000437A1/en unknown
- 2017-06-15 RS RS20211297A patent/RS62550B1/sr unknown
- 2017-06-15 WO PCT/KR2017/006271 patent/WO2017217792A1/fr not_active Ceased
- 2017-06-15 NZ NZ749398A patent/NZ749398A/en unknown
- 2017-06-15 DK DK17813615.6T patent/DK3473621T3/da active
- 2017-06-15 MX MX2018015647A patent/MX385640B/es unknown
- 2017-06-15 CA CA3081033A patent/CA3081033C/fr active Active
- 2017-06-15 PT PT201529591T patent/PT3663292T/pt unknown
- 2017-06-15 HU HUE20152959A patent/HUE056428T2/hu unknown
- 2017-06-15 MX MX2021008988A patent/MX392177B/es unknown
- 2017-06-15 ES ES20152959T patent/ES2898336T3/es active Active
- 2017-06-15 AU AU2017285813A patent/AU2017285813B2/en active Active
- 2017-06-15 PE PE2018003162A patent/PE20190467A1/es unknown
- 2017-06-15 JP JP2018565754A patent/JP6763978B2/ja active Active
- 2017-06-15 PL PL17813615T patent/PL3473621T3/pl unknown
- 2017-06-15 DK DK20152959.1T patent/DK3663292T3/da active
- 2017-06-15 PL PL20152959T patent/PL3663292T3/pl unknown
- 2017-06-15 CN CN202110860586.9A patent/CN113651803B/zh active Active
- 2017-06-15 CN CN201780036968.1A patent/CN109311861B/zh active Active
- 2017-06-15 MY MYPI2018002498A patent/MY203941A/en unknown
- 2017-06-15 MA MA44545A patent/MA44545B2/fr unknown
- 2017-06-15 EP EP20152959.1A patent/EP3663292B1/fr active Active
- 2017-06-15 CA CA3026756A patent/CA3026756C/fr active Active
- 2017-06-15 HR HRP20211670TT patent/HRP20211670T8/hr unknown
- 2017-06-15 SG SG10201911782RA patent/SG10201911782RA/en unknown
- 2017-06-15 MA MA50774A patent/MA50774B1/fr unknown
- 2017-06-15 ES ES17813615T patent/ES2891825T3/es active Active
-
2018
- 2018-12-15 SA SA521422474A patent/SA521422474B1/ar unknown
- 2018-12-15 SA SA518400666A patent/SA518400666B1/ar unknown
- 2018-12-17 PH PH12018550206A patent/PH12018550206A1/en unknown
- 2018-12-17 DO DO2018000287A patent/DOP2018000287A/es unknown
- 2018-12-17 CL CL2018003645A patent/CL2018003645A1/es unknown
- 2018-12-21 CO CONC2018/0014018A patent/CO2018014018A2/es unknown
-
2019
- 2019-01-04 EC ECSENADI2019185A patent/ECSP19000185A/es unknown
- 2019-08-30 US US16/557,180 patent/US10889574B2/en active Active
-
2020
- 2020-04-06 JP JP2020068458A patent/JP7352509B2/ja active Active
-
2021
- 2021-03-22 KR KR1020210036824A patent/KR102379584B1/ko active Active
- 2021-06-21 JP JP2021102648A patent/JP7669206B2/ja active Active
-
2023
- 2023-07-06 JP JP2023111632A patent/JP7773506B2/ja active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA50774B1 (fr) | Procédé de production d'un dérivé de diphénylméthane | |
| EP2038209A4 (fr) | Production de nanostructures | |
| EP1672077A4 (fr) | Procede de production d'acide succinique | |
| EP1947190A4 (fr) | Procédé de production d'acide succinique | |
| EP2003209A4 (fr) | Procede de production d'acide l-amine | |
| FR2929960B1 (fr) | Procede de fabrication de silicium cristallin de qualite photovoltaique par ajout d'impuretes dopantes | |
| EP2340293A4 (fr) | Procédé de production d'huile biologique | |
| MA32255B1 (fr) | Procede pour la preparation de triamides a partir d'ammmoniac et d'amidodichlorures | |
| WO2018220533A3 (fr) | Procédé de production d'un composé optiquement actif | |
| EP2025759A4 (fr) | Procédé de fabrication d'un acide hydroxycarboxylique par une synthèse améliorée de co-enzyme | |
| MA30079B1 (fr) | Procede de synthese de ferri-succinylcaseine | |
| EP2046709A4 (fr) | Procédé de production d'acide succinique | |
| FR2846974B1 (fr) | Procede de production d'une substance cible par fermentation | |
| EP1953808A4 (fr) | Procede de production d' une plaquette epitaxiale et plaquette epitaxiale | |
| EP2211625A4 (fr) | Souches fongiques et procédé de production d'un insecticide par celles-ci | |
| MX2021001732A (es) | Preparacion de intermedio util para la sintesis de inhibidor de sglt. | |
| EP1975157A4 (fr) | PROCÉDÉ DE PRODUCTION D'UN COMPOSÉ CYCLIQUE HÉTÉROAROMATIQUE AYANT UN GROUPE N-Rf | |
| EP1954134A4 (fr) | Procede de synthetisation de derive 2-phenyl-1h-phenantrho[9,10-d]imidazole | |
| EP2157184A4 (fr) | Procédé de production de vanilline à partir de micro-organismes immobilisés par culture de surface | |
| EP4332111A4 (fr) | Procédé de production d'un composé d'acide oligonucléique | |
| DE50213171D1 (de) | Verfahren zur gewinnung von wertstoffen aus organismen | |
| FR3000641B1 (fr) | Nucleon pour la culture de perles et son procede de preparation | |
| MA30033B1 (fr) | Procede de production et de conservation de la forme dun produit extrude constitue d'un materiau cimentaire. | |
| MA35806B1 (fr) | Nouveau procede de synthese du 3-(2-bromo-4,5-dimethoxyphenil) propanenitrile, et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable | |
| EP4317165A4 (fr) | Composé d'acide boronique et son procédé de production |